share_log

12 Health Care Stocks Moving In Friday's Intraday Session

Benzinga ·  Mar 1 12:34

Gainers

  • Adial Pharmaceuticals (NASDAQ:ADIL) stock increased by 58.8% to $3.24 during Friday's regular session. The market value of their outstanding shares is at $5.3 million.
  • BioVie (NASDAQ:BIVI) stock increased by 48.38% to $1.84. The company's market cap stands at $73.3 million.
  • Cardiff Oncology (NASDAQ:CRDF) shares moved upwards by 30.72% to $2.31. The market value of their outstanding shares is at $103.0 million. As per the news, the Q4 earnings report came out yesterday.
  • Myomo (AMEX:MYO) stock increased by 29.73% to $3.97. The market value of their outstanding shares is at $110.6 million.
  • Altamira Therapeutics (NASDAQ:CYTO) stock rose 24.46% to $2.34. The market value of their outstanding shares is at $3.6 million.
  • MSP Recovery (NASDAQ:LIFW) shares moved upwards by 24.11% to $1.05. The company's market cap stands at $15.6 million.

Losers

  • Scilex Holding (NASDAQ:SCLX) shares declined by 36.4% to $1.45 during Friday's regular session. The company's market cap stands at $228.1 million.
  • Precision BioSciences (NASDAQ:DTIL) stock fell 34.0% to $12.21. The market value of their outstanding shares is at $49.6 million.
  • DermTech (NASDAQ:DMTK) shares decreased by 32.12% to $0.87. The company's market cap stands at $29.7 million. As per the news, the Q4 earnings report came out yesterday.
  • Vivani Medical (NASDAQ:VANI) stock decreased by 25.83% to $3.13. The market value of their outstanding shares is at $159.7 million.
  • Gritstone Bio (NASDAQ:GRTS) shares declined by 22.25% to $2.18. The market value of their outstanding shares is at $207.5 million.
  • Humacyte (NASDAQ:HUMA) shares fell 20.81% to $3.44. The market value of their outstanding shares is at $356.8 million.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment